Worth reading
65In focus
Scored from 4 of 5 sectionsDirection
Deterioration
Direction inferred from the company’s description.Scale
500000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of Series 16 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment
発行・処分する株式数500,000Shares
500,000 new shares
Intended allottee
Macquarie Bank Limited (allottee of the previously issued stock acquisition rights)
発行済株式総数
Approximately 0.17% (500,000 shares / 297,121,340 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥16 as of 13 October 2026. The terms provide for adjustment to an amount equivalent to 92% of the closing price on the preceding trading day.
Number of Stock Acquisition Rights
Total issued: 50,000 units; exercised since the previous disclosure: 5,000 units; currently unexercised: 15,000 units
Basis for determining the amount to be paid
The exercise price is adjusted to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the company receives notice of each exercise request, with amounts below ¥1 rounded down.
Most recent equity financing
Announced on 24 March 2025: Issuance through a third-party allotment of Series 15 and Series 16 Stock Acquisition Rights with an exercise price adjustment clause and unsecured corporate bonds (privately placed bonds)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of Series 16 Stock Acquisition Rights with an exercise price adjustment clause issued through a third-party allotment |
| Number of shares to be issued or disposed of | 500,000 new shares |
| Intended allottee | Macquarie Bank Limited (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Approximately 0.17% (500,000 shares / 297,121,340 shares) |
| Total number of issued shares | 297,121,340 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Basis for determining the amount to be paid | The exercise price is adjusted to an amount equivalent to 92% of the closing price on the trading day preceding the date on which the company receives notice of each exercise request, with amounts below ¥1 rounded down. |
| Exercise price | ¥16 as of 13 October 2026. The terms provide for adjustment to an amount equivalent to 92% of the closing price on the preceding trading day. |
| Number of Stock Acquisition Rights | Total issued: 50,000 units; exercised since the previous disclosure: 5,000 units; currently unexercised: 15,000 units |
| Most recent equity financing | Announced on 24 March 2025: Issuance through a third-party allotment of Series 15 and Series 16 Stock Acquisition Rights with an exercise price adjustment clause and unsecured corporate bonds (privately placed bonds) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The disclosure reports that a large number of the stock acquisition rights were exercised, but does not state the reasons or background for the exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.